C12Y 101/01158
Udp-n-acetylmuramate dehydrogenase , i.e. udp-n-acetylenolpyruvoylglucosamine reductase
Official title: UDP-N-acetylmuramate dehydrogenase (1.1.1.158), i.e. UDP-N-acetylenolpyruvoylglucosamine reductase
C12Y101/01158 (Udp-n-acetylmuramate dehydrogenase , i.e. udp-n-acetylenolpyruvoylglucosamine reductase) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 5
- Assignees
- 6
- Inventors
- 45
- Latest grant
- 5 Aug 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
By publication year.
Recent patents
- Cell growth inhibitor and screening method thereof18 Jul 2013US 2013/0184327 A1The University of Tokyo
- Method for Identifying Drug-Sensitizing Antisense DNA Fragments and Use Thereof16 Jun 2011US 2011/0143359 A1Trius Therapeutics, Inc.
- Method for identifying drug-sensitizing antisense DNA fragments and use thereof20 Sep 2007US 2007/0218481 A1Rx3 Pharmaceuticals
- Novel purified polypeptides from streptococcus pneumoniae29 Sep 2005US 2005/0214918 A1Affinium Pharmaceuticals, Inc.
- Novel purified polypeptides from bacteria18 Aug 2005US 2005/0181388 A1Affinium Pharmaceuticals, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.